Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

GYRE THERAPEUTICS, INC.

GYRE · Nasdaq · CIK 0001124105 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

34 Form 4 transaction lines observed in the same window
18 sales · 16 option, withholding, award, gift or other lines

Last qualifying purchase2022-08-09 · USMAN NASSIM · $1.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ye WeiguoChief Operating Officer
○▼○▼○▼○▼○▼○▼○▼○▼○▼○▼○○▼▼○○▼▼○▼○▼
Luo YingChief Executive Officer
▼▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-08-09 · USMAN NASSIM.

Recent Form 4 activity

0Purchases
18Sales
16Other Form 4 lines
9SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING18 sale line(s) · context only
OTHER16 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
1,918,512
Previous report
1,730,215
Avg daily volume
277,117
Days to cover
6.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-08-09USMAN NASSIMPurchase (P)Common Stock3,250USD 0.47USD 1,528SEC filing ↗
2022-08-09Miller Seline E.Purchase (P)Common Stock3,250USD 0.47USD 1,528SEC filing ↗
2022-08-09Blouse Grant E.Purchase (P)Common Stock3,250USD 0.47USD 1,528SEC filing ↗
2022-02-09USMAN NASSIMPurchase (P)Common Stock3,250USD 0.46USD 1,495SEC filing ↗
2022-02-09Miller Seline E.Purchase (P)Common Stock3,250USD 0.46USD 1,495SEC filing ↗
2022-02-09Blouse Grant E.Purchase (P)Common Stock3,250USD 0.46USD 1,495SEC filing ↗
2021-08-09USMAN NASSIMPurchase (P)Common Stock867USD 3.62USD 3,139SEC filing ↗
2021-08-09Levy HowardPurchase (P)Common Stock639USD 3.62USD 2,313SEC filing ↗
2021-08-09Blouse Grant E.Purchase (P)Common Stock1,163USD 3.62USD 4,210SEC filing ↗
2021-02-09USMAN NASSIMPurchase (P)Common Stock582USD 4.81USD 2,799SEC filing ↗
2021-02-09Levy HowardPurchase (P)Common Stock1,670USD 4.81USD 8,033SEC filing ↗
2020-08-10USMAN NASSIMPurchase (P)Common Stock582USD 4.81USD 2,799SEC filing ↗
2020-08-10Levy HowardPurchase (P)Common Stock1,768USD 4.81USD 8,504SEC filing ↗
2020-03-16Levy HowardPurchase (P)Common Stock2,500USD 4.05USD 10,125SEC filing ↗
2020-03-13USMAN NASSIMPurchase (P)Common Stock4,000USD 3.91USD 15,640SEC filing ↗

Form 4 evidence

34 transaction lines in the latest 365-day window; 215 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-18Ye WeiguoSale (S)Common Stock3,000USD 6.35USD 19,050SEC filing ↗
2026-06-18Ye WeiguoOption exercise / conversion (M)Common Stock3,000USD 0.75USD 2,250SEC filing ↗
2026-06-11Ye WeiguoSale (S)Common Stock2,800USD 6.17USD 17,276SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-18Ye WeiguoSale (S)Common Stock3,000USD 6.35USD 19,050SEC filing ↗
2026-06-18Ye WeiguoOption exercise / conversion (M)Common Stock3,000USD 0.75USD 2,250SEC filing ↗
2026-06-11Ye WeiguoSale (S)Common Stock2,800USD 6.17USD 17,276SEC filing ↗
2026-06-11Ye WeiguoOption exercise / conversion (M)Common Stock2,800USD 0.75USD 2,100SEC filing ↗
2026-06-10Ye WeiguoSale (S)Common Stock5,000USD 6.24USD 31,200SEC filing ↗
2026-06-10Ye WeiguoOption exercise / conversion (M)Common Stock5,000USD 0.75USD 3,750SEC filing ↗
2026-06-10Ye WeiguoSale (S)Common Stock6,418USD 6.21USD 39,856SEC filing ↗
2026-06-10Ye WeiguoOption exercise / conversion (M)Common Stock6,418USD 0.75USD 4,814SEC filing ↗
2026-06-09Ye WeiguoSale (S)Common Stock3,000USD 6.15USD 18,450SEC filing ↗
2026-06-09Ye WeiguoOption exercise / conversion (M)Common Stock3,000USD 0.75USD 2,250SEC filing ↗
2026-06-09Ye WeiguoSale (S)Common Stock14,500USD 6.14USD 89,030SEC filing ↗
2026-06-09Ye WeiguoOption exercise / conversion (M)Common Stock14,500USD 0.75USD 10,875SEC filing ↗
2026-06-05Ye WeiguoSale (S)Common Stock15,401USD 6.40USD 98,566SEC filing ↗
2026-06-05Ye WeiguoOption exercise / conversion (M)Common Stock15,401USD 0.75USD 11,551SEC filing ↗
2026-06-04Ye WeiguoSale (S)Common Stock19,575USD 6.13USD 119,995SEC filing ↗
2026-06-04Ye WeiguoOption exercise / conversion (M)Common Stock19,575USD 0.75USD 14,681SEC filing ↗
2026-05-26Ye WeiguoSale (S)Common Stock4,000USD 6.10USD 24,400SEC filing ↗
2026-05-26Ye WeiguoOption exercise / conversion (M)Common Stock4,000USD 0.75USD 3,000SEC filing ↗
2026-05-22Ye WeiguoSale (S)Common Stock3,500USD 6.08USD 21,280SEC filing ↗
2026-05-22Ye WeiguoOption exercise / conversion (M)Common Stock3,500USD 0.75USD 2,625SEC filing ↗
2026-05-21Ye WeiguoSale (S)Common Stock12,820USD 6.15USD 78,843SEC filing ↗
2026-05-21Ye WeiguoOption exercise / conversion (M)Common Stock12,820USD 0.75USD 9,615SEC filing ↗
2026-05-20Ye WeiguoSale (S)Common Stock9,400USD 6.15USD 57,810SEC filing ↗
2026-05-20Ye WeiguoOption exercise / conversion (M)Common Stock9,400USD 0.75USD 7,050SEC filing ↗
2026-05-19Ye WeiguoSale (S)Common Stock9,120USD 6.37USD 58,094SEC filing ↗
2026-05-19Ye WeiguoOption exercise / conversion (M)Common Stock9,120USD 0.75USD 6,840SEC filing ↗
2026-05-18Ye WeiguoSale (S)Common Stock200USD 6.62USD 1,324SEC filing ↗
2026-05-18Ye WeiguoOption exercise / conversion (M)Common Stock200USD 0.75USD 150SEC filing ↗
2026-05-15Ye WeiguoSale (S)Common Stock13,100USD 6.65USD 87,115SEC filing ↗
2026-05-15Ye WeiguoOption exercise / conversion (M)Common Stock13,100USD 0.75USD 9,825SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerGYRE
CIK0001124105
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history215 transaction lines from 2020-01-02 to 2026-06-18
19 P purchase lines · 111 S sale lines · 85 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.